The pleiotropic cytokine interleukin-6 (IL-6) induces acute phase protein expression in HepG2 human hepatoma cells and promotes the growth of mouse B9 hybridoma. The signaling cascades leading to these biological functions are only partially known. We analysed the involvement of MAPK homologues in IL-6 transduction pathways and found that interleukin-6 triggered activation of p38 stress-activated protein kinase (p38) but not of jun kinase. p38 activity was required for biological functions including acute phase protein secretion from HepG2 hepatoma and proliferation of B9 hybridoma cells. Using a reporter gene construct containing a 190 bp promoter fragment of the acute phase protein haptoglobin we found that p38 is involved in transcriptional activation of the haptoglobin promoter by STAT3 but not by NF-IL6. Thus, we present evidence for a role of p38 in IL-6 induced functions and a possible cross-talk between this MAPK homologue and the STAT pathway.
Introduction
Interleukin-6 (IL-6) is a pleiotropic cytokine exhibiting numerous functions and aecting a variety of cells (Kishimoto, 1989) . This pleiotropism implies a complex signaling cascade that enables the development of dierent pathways, resulting in distinct biological functions. The IL-6 receptor consists of a ligand recognition subunit (a) and a gp130 signal transducer (Taga et al., 1989; Hibi et al., 1990) . Upon ligand binding a hexameric structure containing two molecules of each component forms (Murakami et al., 1993; Paonessa et al., 1995) . The signals are transduced exclusively by the cytoplasmic domain of gp130 (Hibi et al., 1990) to which Janus tyrosine kinases (Jaks) constitutively attach (Lutticken et al., 1994) . Speci®c Jaks are activated and phosphorylate gp130 upon IL-6 triggering (Matsuda et al., 1994) . The intracellular domain of gp130 is required for activation of STAT (signal transducers and activators of transcription) proteins which eventually activate transcription from speci®c DNA responsive elements (Sadowski et al., 1993; Akira et al., 1994; Stahl et al., 1995; Zhang et al., 1995) .
One important function of IL-6 is the induction of the acute phase reaction. This is a systemic reaction resulting from tissue injury, trauma or infection and the liver releases a variety of acute phase proteins (APP) into the plasma (Kushner et al., 1987; Gauldie et al., 1992; Baumann and Gauldie, 1994) . Speci®c ciselements on the promoters of APP genes have been de®ned and were shown to bind known transcription factors (Oliviero and Cortese, 1989; Pajovic et al., 1994) . The synthesis of haptoglobin (Hp), an APP protein, is enhanced in acute phase reaction (Pajovic et al., 1994) . The Hp promoter contains binding sites for a few known transcription factors, among which are NF-IL6 (C/EBPb) Pajovic et al., 1994) and STAT3 (Wegenka et al., 1993; Lai et al., 1995) . The activity of these factors is induced by IL-6 and both were shown to be involved in the regulation of APP genes. However, the biochemical processes of signal transduction initiated by IL-6 receptor that regulate the transcriptional activity of NF-IL6 and STAT3 are still obscure. Mitogen activated protein kinases (MAPKs) have been suggested to be mediators of NF-IL6 (Nakajima et al., 1993) and recently of STAT3 (Zhang et al., 1995; David et al., 1995; Wen et al., 1995) . However, no evidence is currently available to conclusively support this notion.
The MAPK family can be divided into two major categories: The extracellular-regulated kinases (ERKs) which are also termed MAPKs (reviewed by Davis, 1993; Marshall, 1994) and the stress-activated protein kinases (SAPKs) (reviewed by Paul et al., 1997; Cohen, 1997) . ERK MAPKs are strongly activated by agonists such as polypeptide growth factors and phorbol-esters (Davis, 1993; Marshall, 1995) , while SAPKs are mainly activated by stress such as that caused by heat and osmotic shock, UV light, inhibitors of protein synthesis and proin¯ammatory cytokines, e.g. interleukin-1 (IL-1) and tumor necrosis factor-a (TNF-a) (Rouse et al., 1994; Freshney et al., 1994) . SAPKs consist of two major groups of MAPK homologues: JNKs and p38 (Paul et al., 1997; Cohen, 1997) . Each member of the MAPKs and the SAPKs is activated by dual speci®city kinases which phosphorylate these serine/threonine kinases on speci®c threonine and tyrosine residues (Paul et al., 1997; Cohen, 1997) . The upstream activators of the SAPKs have also been studied and at least four dual speci®city kinases were shown to be involved in activation of the SAPKs (Sanchez et al., 1994; Lin et al., 1995; Derijard et al., 1995; Raingeaud et al., 1996; Yao et al., 1997; Moriguchi et al., 1997) .
Activation of ERK MAPKs has been detected in IL-6 induced systems (Kishimoto and Taga, 1992; Boulton et al., 1994) . However, whether these kinases play a role in the activation of APP genes seems uncertain. Recently, particular growth factors and cytokines, such as IL-2, IL-3, IL-7, erythropoietin, SLF, CSF-1 and GM-CSF, were shown to activate p38 in dierent cell lines (Nagata et al., 1997; Crawley et al., 1997; Foltz et al., 1997) . Here we show that one of the major signal transduction pathways induced by IL-6 involves p38, but not JNK. Our results imply a role for p38 in APP secretion from HepG2 cells via cross-talk with the STAT pathway and a role for p38 in IL-6 induced proliferation of B9 hybridoma cells.
Results

IL-6 activates p38 in hepatoma cells
We studied the signaling pathways evoked by IL-6, in HepG2 hepatoma cells, that result in APP secretion. The ERK MAPK pathway has already been shown to be involved in IL-6 signaling in dierent biological systems (Kishimoto and Taga, 1992; Boulton et al., 1994) . To analyse the possible involvement of the MAPK homologue, p38 (Freshney et al., 1994) , HepG2 cell extracts were examined by Western blotting with antibodies to the double phosphorylated form of p38 ( Figure 1a ). As shown, p38 phosphorylation was elevated in IL-6 treated cells. An immunoprecipitation kinase assay, using antibodies against p38 where GST ± ATFII served as an in vitro substrate showed that p38 activity was enhanced sixfold upon induction with IL-6 (Figure 1b) . Sodium arsenite and anisomycin, which are both potent activators of p38, had a comparable eect. Figure 1 p38 is activated by IL-6 in hepatoma cells. (a) Time course analysis of IL-6 induced p38 activity was performed by subjecting equal amounts of total cell lysates to SDS ± PAGE followed by probing with speci®c antibodies to the double phosphorylated form of p38 (upper panel) . Densitometric analysis of the phosphorylated p38 is shown in the attached graph (lower panel). To show that equal amounts of protein were loaded, the blots were reprobed with speci®c antibodies to p38 (middle panel). (b) Analysis of IL-6 induced p38 activity was performed by immunoprecipitation complex kinase assay. Kinase activity was measured using GST-ATFII as a substrate. Phosphorylated substrate was fractioned by SDS ± PAGE, transferred to nitrocellulose and signals were detected by phosphoimager. Quantitation of the incorporated phosphate is presented in the graph as fold induction over basal activity. (c) Activity of MAPKAP-K2 upon IL-6 stimulation was measured by immunocomplex kinase assay with antibodies against MAPKAP-K2 using the MAPKAP-K2 speci®c peptide substrate. Samples were loaded on p81 paper and incorporation of the phosphate was measured and is presented as fold induction over its basal activity. (d) IL-6 induced JNK phosphorylation was measured as described for ERK MAPK activation with speci®c antibodies to the activated form of JNK (NEB) (upper panel) . Densitometric analysis of the phosphorylated proteins is presented in the adjacent graph (lower panel). Sodium arsenite (arsenite) and anisomycin (aniso) were used as controls MAPK activated protein kinase-2 (MAPKAP-K2) is an established downstream substrate for p38 (Ben-Levy et al., 1995) . Endogenous MAPKAP-K2 was immunoprecipitated from HepG2 cells 10 min after stimulation with IL-6. Immunocomplex kinase assay was performed using a speci®c peptide substrate for MAP-KAP-K2 (Stokoe et al., 1992) . As shown in Figure 1c , MAPKAP-K2 activity increased after induction with IL-6.
Since conditions, such as stress and proin¯ammatory cytokines, that activate the p38 pathway also induce the MAPK homologue, jun kinase (JNK), we examined whether this third member of the MAPK family, is activated by IL-6. As shown in Figure 1d , JNK was not phosphorylated in IL-6 induced HepG2 cells, whereas anisomycin and sodium arsenite caused extensive phosphorylation of both JNK1 and JNK2. This lack of activation of JNK in IL-6 induced cells was also observed using an independently derived antiphospho JNK antibody (results not shown). It can be concluded therefore, that the IL-6 signaling pathway involves p38, whereas JNK does not seem to play a major role in this process.
SB203580, a p38 inhibitor, reduces APP secretion from hepatoma cells
Induction of the HepG2 cells with IL-6 leads to secretion of APP (Baumann et al., 1990) . To evaluate the biological signi®cance of p38 activation in IL-6 induced APP secretion, we made use of a pyridinil imidazole compound (SB203590) which has been shown to speci®cally inhibit the p38 pathway . HepG2 cells exposed to SB203580 1 h prior to stimulation with IL-6, were examined 24 h later for secretion of two APPs, haptoglobin (Hp) and a 1 -acid glycoprotein (AGP). Aliquots from the conditioned medium were examined by Western blotting using anti-haptoglobin antibodies ( Figure 2a ) or antibodies to a 1 -acid glycoprotein ( Figure 2b ). In both cases SB203580 interfered with IL-6 induced APP secretion. It is noteworthy that 10 ± 20 mM of the inhibitor were sucient to achieve inhibition of Hp down to the basal level. Similarly, SB203580 at 10 ± 20 mM reduced IL-6 induced MAP-KAP-K2 activation to background levels (results not shown).
p38 is involved in transcriptional activation from a 190 bp haptoglobin promoter IL-6 induced transcription from the Hp promoter can be analysed by a reporter gene construct of a de®ned 190 bp region in the Hp promoter (Baumann et al., 1990) . We sub-cloned the 190 bp fragment upstream to a luciferase reporter gene and transfected HepG2 cells with this construct. Luciferase activity was induced upon IL-6 treatment in a dose-dependent manner (Figure 3 ± upper insert) . Similarly transfected cells were treated with speci®c p38 or MEK inhibitors, SB203580 or PD98059 (Alessi et al., 1995) , respectively, in the presence of IL-6 for 12 ± 16 h. The p38 speci®c inhibitor reduced IL-6 activation of the promoter (Figure 3 and Figure 4d ). By contrast, PD98059, the ERK MAPK pathway inhibitor, had no such eect, while as expected, it was potent in inhibiting IL-6 induced phosphorylation of the ERK MAPK in the same cells (Figure 3 ± lower insert). This implies that p38, but not ERK MAPK, is required for IL-6 induced activation of the 190 bp Hp promoter.
Figure 2 p38 is involved in IL-6 induced APP secretion from hepatoma cells. Secretion of (a) haptoglobin (Hp) and (b) a 1 -acid glycoprotein (AGP) induced by IL-6 was measured in the presence or in the absence of p38 inhibitor (p38Inh.), SB203580, added at the indicated concentrations (a) or at 10 mM (b), 1 h prior to induction by IL-6. Aliquots of protein released into the growth medium were analysed 24 h later by Western blotting Figure 3 p38 is involved in activation of a 190 bp Hp promoter by IL-6. HepG2 cells were transfected with a 190 bp Hp promoter reporter construct and induced with IL-6 (upper insert). Cells were exposed to 10 mM SB203580 (Smithklin Beetchem), p38 speci®c inhibitor (p38Inh.) and to PD98059, MEK inhibitor (MEKInh.), 1 h prior to IL-6 induction. Luciferase activity was measured and is given in arbitrary units. Inhibition of IL-6 induced ERK MAPK phosphorylation by MEK inhibitor is shown (lower insert). Results of one representative experiment out of ®ve performed are shown p38 is involved in IL-6 signaling A Zauberman et al p38 is involved in IL-6 induced transcriptional activation of the haptoglobin promoter via STAT3 but not via NF-IL6
One of the transcription factors that binds to and activates the Hp promoter is NF-IL6 . Another transcription factor, STAT3, also termed APRF (acute phase response factor) controls APP promoter activation in hepatoma cells by binding to an IL-6 response element (Wegenka et al., 1993) . We cotransfected STAT3 or STAT1 cDNA in expression vectors along with the reporter construct and examined the responses to IL-6 induction. STAT3 overexpression combined with IL-6 induction resulted in a high increase in luciferase activity, whereas STAT1 overexpression had no eect (Figure 4b ). These results con®rm previous ®ndings indicating that STAT3 rather than STAT1 interacts with the Hp promoter to maintain its IL-6 inducibility (Kim and Baumann, 1997) . The haptoglobin promoter activity, enhanced in IL-6 induced cells overexpressing STAT3, declined upon addition of the p38 inhibitor in a dose dependent manner (Figure 4c ). Although this inhibitor slightly aected basal Hp promoter activity (Figure 3 ) and the endogenous p38 mediated transcription from the Hp promoter (Figure 4d ) it had a far more signi®cant eect on IL-6 induced activation of this promoter via STAT3 (Figure 4c ). These results suggest that in contrast to the lack of dependence of NF-IL6 on p38 for activation of the Hp promoter, IL-6 activation of transcription through STAT3 requires functional p38. To further control for the speci®city of eect of the p38 inhibitor we examined two additional unrelated promoterreporter systems. As shown in Figure 4e , SB203580, had no eect on transcription from Gal4 DNA binding domain or from CMV promoter.
p38 is involved in the proliferation of the IL-6 dependent B9 hybridoma
The requirement for p38 activity in IL-6 signaling may be unique to the HepG2 cell line, or alternatively is a general feature in the IL-6 signaling cascade. We examined therefore, an additional IL-6 inducible system, i.e. the B9 hybridoma cell line, which is IL-6 dependent for survival and growth (Helle et al., 1988) . [ 3 H]thymidine incorporation was measured in logarithmically growing B9 cells in the presence or in the absence of MAPK inhibitors. As shown in Figure 5a , MEK inhibitor PD98059, had no eect on IL-6 induced cell proliferation. In contrast, 10 mM of SB203580 caused complete growth inhibition. A comparison between B9 and HL-60 cells showed that the growth of HL-60 cells was almost unaected by the inhibitor (Figure 5b ). These results obtained with the B9 cell line correlate well with the pattern of phosphorylation of the corresponding kinases in these cells.
Thus, no ERK MAPK phosphorylation was observed upon IL-6 induction, despite the fact that this kinase was highly phosphorylated by sodium arsenite stimulation (Figure 5c ± upper panel) . These results were veri®ed using anti-phospho MAPK antibodies from two independent sources (results not shown). In contrast, time-dependent phosphorylation of p38 was observed following stimulation with IL-6 (Figure 5d ± upper panel) . Taken together, the results suggest that the p38 pathway rather than ERK MAPK is essential for IL-6 induced growth of B9 hybridoma cells used in this study.
Discussion
A large body of evidence links ERK MAPK and its upstream activator MAPK kinase to a wide variety of To show that equal amounts of proteins were loaded, the blots were reprobed with speci®c antibodies to ERK MAPK (c ± lower panel) or to p38 (d ± lower panel). Sodium arsenite (arsenite) and anisomycin (aniso) were used as controls p38 is involved in IL-6 signaling A Zauberman et al biological processes (Davis, 1993; Marshall, 1994) . Much less is known about the biological functions of the MAPK homologues, the SAPKs, which are activated by stress and proin¯ammatory cytokines (Paul et al., 1997; Cohen, 1997) . Since IL-6 is a major regulator of the acute phase response which is associated with conditions of injury, trauma and in¯ammation, we reasoned that IL-6 may activate signaling pathways similar to those used by other agents involved in in¯ammation. We identi®ed a novel signal transduction pathway triggered by IL-6 as evidenced by the phosphorylation and activation of p38. Since the anti-p38 antibodies used do not discriminate between the dierent isotypes of this protein it is not possible to state which of these is IL-6 induced. The study further suggested the involvement of p38 in IL-6 induced APP secretion. SB203580, which has been shown to speci®cally inhibit p38 (Lee et al., 1994; Cuenda et al., 1995; Cohen, 1997) by binding the ATP pocket of p38 Tong et al., 1997) enables the subsequent inhibition of endogenous p38 activity in cultured cells. The inhibitor abolished IL-6 induced Hp secretion at 10 ± 20 mM. The use of this inhibitor thus veri®ed the requirement of functional p38 for the transduction of the IL-6 signal.
By making use of a reporter gene construct we could show that the 190 bp Hp promoter was dependent on p38 for its IL-6 induced activation. This region has already been studied in detail and transcription factors which bind to and activate this promoter region have been identi®ed and their binding sites have been determined (Pajovic et al., 1994; Kim and Baumann, 1997) . Two of these transcription factors are NF-IL6 and STAT3. Using SB203580, we found that p38 activity was required for STAT3 but not for NF-IL6 activation of the promoter upon induction with IL-6. Although coupling of MAPKs and STATs has been previously suggested (Ihle, 1996) , this issue is still unresolved. We provide here initial evidence showing that p38 is involved in activation of STAT3. The activation of STAT3 by p38 may involve unknown intermediate proteins since we were unable to detect direct phosphorylation of STAT3 by p38 or by MAPKAP-K2 (results not shown). This concept is supported by studies showing that p38 is involved in transcriptional activation of a speci®c transcription factor without directly or indirectly aecting its phosphorylation level or DNA binding activity (Beyaert et al., 1996) . A role of p38 has been implicated in transcription activation by phosphorylation of the transcription factor CHOP (Wang and Ron, 1996) . Our preliminary results suggest that p38 may interact with proteins that bind to DNA elements and interact with the STAT3 protein to activate transcription. This possibility has been previously suggested (Cohen, 1997) .
The p38 inhibitor aected both IL-6 induced and basal secretion of APP and had some slight aect also on IL-6 induced transcription from the Hp promoter.
Since our experiments established a role for p38 in IL-6 induced transcriptional activation of the haptoglobin promoter through STAT3, and lack of response of other promoters to p38 inhibitor we propose that thè basal' activity of Hp promoter may be due to serum cytokines present at low concentration in the growth medium. These could be IL-6 cytokine family members and could therefore transduce via a p38 dependent pathway.
We studied the involvement of p38 in IL-6 signaling using an additional model system, i.e. the B9 hybridoma cell line which depends on IL-6 for growth and survival. Our results with the inhibitors to the MAPKs showed that p38, but not ERK MAPK, was required for cell proliferation. No detectable activation of ERK MAPK pathway could be observed. Ogata et al. (1997) showed that ERK MAPK is a major IL-6 signal transducer in B9 cells. This discrepancy could be due to dierences in the experimental systems used since complete serum free medium and treatment with sodium o-vanadate has been reported (Ogata et al., 1997) while we grew the cells in 5% FCS. Our results, as well as other recent reports, showed that cytokines and growth factors induce p38 activation in various cell lines (Nagata et al., 1997; Crawley et al., 1997; Foltz et al., 1997) and that p38 is involved in the control of cell proliferation (Zechner et al., 1997; Crawley et al., 1997) . In addition, we observed dramatic activation of ERK MAPK in arsenite induced B9 cells ( Figure 5 ). This unexpected observation is substantiated by the recent demonstration that arsenite is an inducer of ERK MAPK although in this case activation occurred slowly (Ludwig et al., 1998) .
In summary, we have de®ned a novel kinase pathway for signal transduction by IL-6. The biological signi®cance of IL-6 induced p38 signaling in APP secretion was also demonstrated. p38 activity was shown to be essential for Hp promoter activity via transcription factor STAT3 and not via NF-IL6. The results imply that two major signaling pathways, MAPKs and STATs, are probably coupled and that this coupling is required for biological functions.
Materials and methods
Cell lines and cell culture
Human hepatoma HepG2, and myeloid HL-60, cell lines were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% Fetal Calf Serum (FCS) (Beth Haemek, Israel), 20 mM L-glutamine, 60 mg/ml penicillin, 100 mg/ml streptomycin and 50 mg/l Kanamycin. B9, murine IL-6 dependent hybridoma cells (Helle et al., 1988) , were grown in RPMI 1640 supplemented with 5% FCS, 50 mM b-mercaptoethanol and 10 U/ml human recombinant IL-6.
Reagents
Recombinant, N-terminally truncated, human IL-6 (mutein) (Breton et al., 1995) was kindly provided by Pharmacia Biocenter (Nerviano, Italy). 100 u/ml IL-6 were used in all the experiments unless indicated otherwise. p38 inhibitor, SB203580, was a gift from Dr Peter Young (SmithKline Beecham, PA, USA) or purchased from Calbiochem (La Jolla, CA, USA) or from Upstate Biotechnology (Lake Placid, NY, USA). The latter two had identical eects whereas the former one was threefold more active. Therefore, proportionally more of the inhibitor was used in experiments using the former product. MEK inhibitor, PD98059, was purchased from Biomol (PA, USA). 10 mM SB203580 and 10 mM PD98059, were used unless indicated otherwise. Cells were exposed to 0.5 mM sodium arsenite for 30 min and 10 mg/ml anisomycin for 15 min. Anti phosphoprotein 
Western blotting
Cells were immediately lysed in a sample buer (2% bmercaptoethanol or DTT, 4% SDS, 50 mM Tris HCl pH 6.8, 10% glycerol, 0.01% bromophenol blue), and boiled for 5 min. Extracts were subjected to SDS ± PAGE blotted and probed with speci®c antibodies. Chemiluminescent signals were generated by incubation with the ECL reagent. The gels were exposed to X-ray ®lm.
DNA constructs
prHp(190)-CT plasmid was a gift from Dr Heintz Baumann (Roswell Park Cancer Institute, Bualo, NY, USA). The 190 bp Hp promoter fragment was subcloned upstream of the luciferase gene into pGL3-basic plasmid (Promega, Madison, USA). cDNA of NF-IL6 was sub-cloned from pBlue610, a gift from Dr Shizuo Akira (Hyogo College of Medicine, Hyogo, Japan), into pcDNA3 expression plasmid (Invitrogene, The Netherlands). STAT1 and STAT3 were expressed in pRc/CMV (Invitrogene). CMV promoter and Gal4 DNA binding site upstream of luciferase activated by a fusion protein of VP16 activation domain fused to Gal4 DNA binding domain were kindly provided by Dr Yosef Shaul, Weizmann Institute, Israel.
Luciferase assay
Transient transfections with the appropriate vectors were carried out using the calcium phosphate method. Transfection eciency was normalized to bgalactosidase activity by cotransfection of 0.5 mg CMV bgal expression vector. Cells were plated in six well plates (Falcon) and transfected with 0.5 mg of the reporter plasmid and a total of 2 mg of dierent DNA constructs in a ®nal volume of 1.5 ml. Six hours after transfection, cells underwent glycerol shock and 24 h later were serum starved and incubated in the presence or absence of IL-6 and inhibitors for 12 ± 16 h. Cells were then harvested and luciferase activity in cell lysates was determined according to standard procedure with the aid of a Turner Designs Luminometer.
Immunocomplex-kinase assay
Cell extracts were prepared as previously described . Antibodies to p38 or to MAPKAP-K2 were bound to Sepharose protein G and immunoprecipitation was performed. Protein bound to the beads was then incubated with speci®c substrates: ATFII for p38 and speci®c peptide substrate for MAPKAP-K2 (Stokoe et al., 1992) . Kinase assay was performed as already described (BenLevy et al., 1995) . Labeled ATFII was subjected to SDS ± PAGE gel and blotted onto nitrocellulose. Signals were detected by phosphoimager. MAPKAP-K2 peptide substrate was loaded on p81 paper and incorporated phosphate was measured by b-counter.
